These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25228446)

  • 1. Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial.
    Conrad C; Lymp J; Thompson V; Dunn C; Davies Z; Chatfield B; Nichols D; Clancy J; Vender R; Egan ME; Quittell L; Michelson P; Antony V; Spahr J; Rubenstein RC; Moss RB; Herzenberg LA; Goss CH; Tirouvanziam R
    J Cyst Fibros; 2015 Mar; 14(2):219-27. PubMed ID: 25228446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of short-term, high-dose oral N-acetylcysteine treatment on oxidative stress markers in cystic fibrosis patients with chronic P. aeruginosa infection -- a pilot study.
    Skov M; Pressler T; Lykkesfeldt J; Poulsen HE; Jensen PØ; Johansen HK; Qvist T; Kræmer D; Høiby N; Ciofu O
    J Cyst Fibros; 2015 Mar; 14(2):211-8. PubMed ID: 25458464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung disease.
    Taylor-Cousar JL; Wiley C; Felton LA; St Clair C; Jones M; Curran-Everett D; Poch K; Nichols DP; Solomon GM; Saavedra MT; Accurso FJ; Nick JA
    J Cyst Fibros; 2015 Mar; 14(2):228-36. PubMed ID: 25466700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis.
    Konstan MW; Döring G; Heltshe SL; Lands LC; Hilliard KA; Koker P; Bhattacharya S; Staab A; Hamilton A;
    J Cyst Fibros; 2014 Mar; 13(2):148-55. PubMed ID: 24440167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease.
    Moss RB; Mayer-Hamblett N; Wagener J; Daines C; Hale K; Ahrens R; Gibson RL; Anderson P; Retsch-Bogart G; Nasr SZ; Noth I; Waltz D; Zeitlin P; Ramsey B; Starko K
    Pediatr Pulmonol; 2005 Mar; 39(3):209-18. PubMed ID: 15573395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis.
    Tirouvanziam R; Conrad CK; Bottiglieri T; Herzenberg LA; Moss RB; Herzenberg LA
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4628-33. PubMed ID: 16537378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine.
    van Overveld FJ; Demkow U; Górecka D; de Backer WA; Zielinski J
    J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():135-42. PubMed ID: 16204787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, safety and effect on biomarkers of AZD9668 in cystic fibrosis.
    Elborn JS; Perrett J; Forsman-Semb K; Marks-Konczalik J; Gunawardena K; Entwistle N
    Eur Respir J; 2012 Oct; 40(4):969-76. PubMed ID: 22267768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of thiol-based antioxidant therapeutics in cystic fibrosis sputum: Focus on myeloperoxidase.
    Vasu VT; de Cruz SJ; Houghton JS; Hayakawa KA; Morrissey BM; Cross CE; Eiserich JP
    Free Radic Res; 2011 Feb; 45(2):165-76. PubMed ID: 20954832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis.
    Martin SL; Downey D; Bilton D; Keogan MT; Edgar J; Elborn JS;
    Pediatr Pulmonol; 2006 Feb; 41(2):177-83. PubMed ID: 16372352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral glycine on the clinical, spirometric and inflammatory status in subjects with cystic fibrosis: a pilot randomized trial.
    Vargas MH; Del-Razo-Rodríguez R; López-García A; Lezana-Fernández JL; Chávez J; Furuya MEY; Marín-Santana JC
    BMC Pulm Med; 2017 Dec; 17(1):206. PubMed ID: 29246256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digitoxin for Airway Inflammation in Cystic Fibrosis: Preliminary Assessment of Safety, Pharmacokinetics, and Dose Finding.
    Zeitlin PL; Diener-West M; Callahan KA; Lee S; Talbot CC; Pollard B; Boyle MP; Lechtzin N
    Ann Am Thorac Soc; 2017 Feb; 14(2):220-229. PubMed ID: 28006108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhalation treatment with glutathione in patients with cystic fibrosis. A randomized clinical trial.
    Griese M; Kappler M; Eismann C; Ballmann M; Junge S; Rietschel E; van Koningsbruggen-Rietschel S; Staab D; Rolinck-Werninghaus C; Mellies U; Köhnlein T; Wagner T; König S; Teschler H; Heuer HE; Kopp M; Heyder S; Hammermann J; Küster P; Honer M; Mansmann U; Beck-Speier I; Hartl D; Fuchs C; ; Hector A
    Am J Respir Crit Care Med; 2013 Jul; 188(1):83-9. PubMed ID: 23631796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Denufosol tetrasodium in patients with cystic fibrosis and normal to mildly impaired lung function.
    Accurso FJ; Moss RB; Wilmott RW; Anbar RD; Schaberg AE; Durham TA; Ramsey BW;
    Am J Respir Crit Care Med; 2011 Mar; 183(5):627-34. PubMed ID: 21169471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pentoxifylline on sputum neutrophil elastase and pulmonary function in patients with cystic fibrosis: preliminary observations.
    Aronoff SC; Quinn FJ; Carpenter LS; Novick WJ
    J Pediatr; 1994 Dec; 125(6 Pt 1):992-7. PubMed ID: 7996376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot Randomized Controlled Trial Evaluating the Effect of Hypertonic Saline With and Without Hyaluronic Acid in Reducing Inflammation in Cystic Fibrosis.
    Brivio A; Conese M; Gambazza S; Biffi A; Tirelli AS; Russo M; Foà M; Colombo C
    J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):482-489. PubMed ID: 27149365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylcysteine in cystic fibrosis and Pseudomonas aeruginosa infection: clinical score, spirometry and ciliary motility.
    Stafanger G; Koch C
    Eur Respir J; 1989 Mar; 2(3):234-7. PubMed ID: 2659383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis.
    Laguna TA; Williams CB; Brandy KR; Welchlin-Bradford C; Moen CE; Reilly CS; Wendt CH
    J Cyst Fibros; 2015 May; 14(3):334-40. PubMed ID: 25456770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of N-acetylcysteine supplementation on oxidative stress status and alveolar inflammation in people exposed to asbestos: a double-blind, randomized clinical trial.
    Alfonso H; Franklin P; Ching S; Croft K; Burcham P; Olsen N; Reid A; Joyce D; de Klerk N; Musk AB
    Respirology; 2015 Oct; 20(7):1102-7. PubMed ID: 26172395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis.
    Calabrese C; Tosco A; Abete P; Carnovale V; Basile C; Magliocca A; Quattrucci S; De Sanctis S; Alatri F; Mazzarella G; De Pietro L; Turino C; Melillo E; Buonpensiero P; Di Pasqua A; Raia V
    J Cyst Fibros; 2015 Mar; 14(2):203-10. PubMed ID: 25458463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.